BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29691673)

  • 21. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
    Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
    Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
    Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
    Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
    Chen H; Werner S; Tao S; Zörnig I; Brenner H
    Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
    Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
    Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of diagnostic ELISA-based tests for the detection of auto-antibodies against tumor antigens in human serum.
    Stefatić D; Riederer M; Balić M; Dandachi N; Stanzer S; Janesch B; Resel M; Ler D; Samonigg H; Bauernhofer T
    Bosn J Basic Med Sci; 2008 Aug; 8(3):245-50. PubMed ID: 18816257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.
    Li J; Dai L; Lei N; Xing M; Li P; Luo C; Casiano CA; Zhang JY
    Oncotarget; 2016 Jul; 7(28):43546-43556. PubMed ID: 27286458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53.
    Hurley LC; Levin NK; Chatterjee M; Coles J; Muszkat S; Howarth Z; Dyson G; Tainsky MA
    Cancer Biomark; 2020; 27(3):407-421. PubMed ID: 32083570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma.
    Qin J; Wang S; Shi J; Ma Y; Wang K; Ye H; Zhang X; Wang P; Wang X; Song C; Dai L; Wang K; Jiang B; Zhang J
    Cancer Sci; 2019 Jun; 110(6):1829-1841. PubMed ID: 30950146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibody Signatures Combined with Epstein-Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.
    Peng YH; Xu YW; Huang LS; Zhai TT; Dai LH; Qiu SQ; Yang YS; Chen WZ; Zhang LQ; Li EM; Xu LY
    Cancer Prev Res (Phila); 2015 Aug; 8(8):729-36. PubMed ID: 25990085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum p53 antibody assay: evaluation in colorectal cancer].
    Hammel P; Soussi T
    Rev Med Interne; 2000 Feb; 21(2):167-73. PubMed ID: 10703073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer.
    Hong CQ; Weng XF; Huang XC; Chu LY; Wei LF; Lin YW; Chen LY; Liu CT; Xu YW; Peng YH
    J Cancer; 2021; 12(9):2747-2755. PubMed ID: 33854634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy.
    Lechpammer M; Lukac J; Lechpammer S; Kovacević D; Loda M; Kusić Z
    Int J Colorectal Dis; 2004 Mar; 19(2):114-20. PubMed ID: 14634775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.
    Milne K; Barnes RO; Girardin A; Mawer MA; Nesslinger NJ; Ng A; Nielsen JS; Sahota R; Tran E; Webb JR; Wong MQ; Wick DA; Wray A; McMurtrie E; Köbel M; Kalloger SE; Gilks CB; Watson PH; Nelson BH
    PLoS One; 2008; 3(10):e3409. PubMed ID: 18923710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secreted recombinant P53 protein from Pichia pastoris is a useful antigen for detection of serum p53: autoantibody in patients with advanced colorectal adenocarcinoma.
    Abdelmoula-Souissi S; Zouari N; Miladi-Abdenadher I; Yaich-Kolsi O; Ayadi-Masmoudi I; Khabir A; Masmoudi H; Frikha M; Mokdad-Gargouri R
    Mol Biol Rep; 2013 May; 40(5):3865-72. PubMed ID: 23526366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-p53 autoantibody in colorectal cancer: prognostic significance in long-term follow-up.
    Suppiah A; Alabi A; Madden L; Hartley JE; Monson JR; Greenman J
    Int J Colorectal Dis; 2008 Jun; 23(6):595-600. PubMed ID: 18330580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-associated autoantibodies to MUC1 and MUC4--a blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening.
    Pedersen JW; Gentry-Maharaj A; Nøstdal A; Fourkala EO; Dawnay A; Burnell M; Zaikin A; Burchell J; Papadimitriou JT; Clausen H; Jacobs I; Menon U; Wandall HH
    Int J Cancer; 2014 May; 134(9):2180-88. PubMed ID: 24122770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies in breast cancer: their use as an aid to early diagnosis.
    Chapman C; Murray A; Chakrabarti J; Thorpe A; Woolston C; Sahin U; Barnes A; Robertson J
    Ann Oncol; 2007 May; 18(5):868-73. PubMed ID: 17347129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.